Smithfield Trust’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28K | Hold |
1,869
| – | – | ﹤0.01% | 665 |
|
|
2025
Q1 | $28K | Sell |
1,869
-69
| -4% | -$1.03K | ﹤0.01% | 651 |
|
|
2024
Q4 | $27K | Sell |
1,938
-1,490
| -43% | -$20.8K | ﹤0.01% | 671 |
|
|
2024
Q3 | $49K | Buy |
3,428
+1,490
| +77% | +$21.3K | ﹤0.01% | 563 |
|
|
2024
Q2 | $26K | Hold |
1,938
| – | – | ﹤0.01% | 652 |
|
|
2024
Q1 | $27K | Hold |
1,938
| – | – | ﹤0.01% | 662 |
|
|
2023
Q4 | $28K | Sell |
1,938
-276
| -12% | -$3.99K | ﹤0.01% | 642 |
|
|
2023
Q3 | $34K | Hold |
2,214
| – | – | ﹤0.01% | 590 |
|
|
2023
Q2 | $35K | Hold |
2,214
| – | – | ﹤0.01% | 605 |
|
|
2023
Q1 | $37K | Hold |
2,214
| – | – | ﹤0.01% | 574 |
|
|
2022
Q4 | $34K | Hold |
2,214
| – | – | ﹤0.01% | 572 |
|
|
2022
Q3 | $29K | Hold |
2,214
| – | – | ﹤0.01% | 588 |
|
|
2022
Q2 | $32K | Hold |
2,214
| – | – | ﹤0.01% | 600 |
|
|
2022
Q1 | $32K | Hold |
2,214
| – | – | ﹤0.01% | 621 |
|
|
2021
Q4 | $30K | Hold |
2,214
| – | – | ﹤0.01% | 643 |
|
|
2021
Q3 | $36K | Hold |
2,214
| – | – | ﹤0.01% | 612 |
|
|
2021
Q2 | $37K | Hold |
2,214
| – | – | ﹤0.01% | 596 |
|
|
2021
Q1 | $40K | Hold |
2,214
| – | – | ﹤0.01% | 591 |
|
|
2020
Q4 | $40K | Hold |
2,214
| – | – | ﹤0.01% | 564 |
|
|
2020
Q3 | $39K | Hold |
2,214
| – | – | ﹤0.01% | 543 |
|
|
2020
Q2 | $40K | Hold |
2,214
| – | – | ﹤0.01% | 524 |
|
|
2020
Q1 | $34K | Sell |
2,214
-669
| -23% | -$10.3K | ﹤0.01% | 503 |
|
|
2019
Q4 | $57K | Sell |
2,883
-503
| -15% | -$9.95K | 0.01% | 502 |
|
|
2019
Q3 | $59K | Sell |
3,386
-840
| -20% | -$14.6K | 0.01% | 501 |
|
|
2019
Q2 | $75K | Buy |
4,226
+503
| +14% | +$8.93K | 0.01% | 458 |
|
|
2019
Q1 | $76K | Buy |
+3,723
| New | +$76K | 0.01% | 439 |
|